Gurlek Gokcebay, D. Et Al. 2018. Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura. Transfusion and Apheresis Science , vol.57, no.3 , 416-417.

Gurlek Gokcebay, D., Guzelkucuk, Z., & Yarali, N., (2018). Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura. Transfusion and Apheresis Science , vol.57, no.3, 416-417.

Gurlek Gokcebay, Dilek, Zeliha Guzelkucuk, And HÜSNİYE NEŞE YARALI. "Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura," Transfusion and Apheresis Science , vol.57, no.3, 416-417, 2018

Gurlek Gokcebay, Dilek G. Et Al. "Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura." Transfusion and Apheresis Science , vol.57, no.3, pp.416-417, 2018

Gurlek Gokcebay, D. Guzelkucuk, Z. And Yarali, N. (2018) . "Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura." Transfusion and Apheresis Science , vol.57, no.3, pp.416-417.

@article{article, author={Dilek Gurlek Gokcebay Et Al. }, title={Long-term efficiency of rituximab therapy in children with chronic immune thrombocytopenic purpura}, journal={Transfusion and Apheresis Science}, year=2018, pages={416-417} }